Recent studies have shown that Increased ROS levels decrease mitochondrial membrane potential and ATP levels, and that dihydrotanshinone triggers porimin-dependent oncosis by ros-mediated mitochondrial dysfunction in non-small-cell lung cancer [10]. The gene discussed is TMEM123; the disease is non-small cell lung carcinoma.